Healthcare - Biotechnology - NASDAQ - US
$ 0.007
0 %
$ 34.1 K
Market Cap
0.0
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
61.41%
Net Income
Estimate
54.86%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Calithera Biosciences, Inc.
CALA has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart CALA
EBIT FORECAST
EBIT Forecast Chart CALA
NET INCOME FORECAST
Net Income Chart CALA